+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Dry Eye Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Dry Eye Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Duchenne Muscular Dystrophy - Pipeline Insight, 2025 - Product Thumbnail Image

Duchenne Muscular Dystrophy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 200 Pages
  • Global
From
Dysautonomia Or Autonomic Dysfunction - Pipeline Insight, 2025 - Product Thumbnail Image

Dysautonomia Or Autonomic Dysfunction - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Dyschromia - Pipeline Insight, 2025 - Product Thumbnail Image

Dyschromia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Dyslipidemia - Pipeline Insight, 2025 - Product Thumbnail Image

Dyslipidemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Early Cardiogenic Shock (CS) - Pipeline Insight, 2025 - Product Thumbnail Image

Early Cardiogenic Shock (CS) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Eosinophilic Disorder - Pipeline Insight, 2025 - Product Thumbnail Image

Eosinophilic Disorder - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Epilepsy - Pipeline Insight, 2025 - Product Thumbnail Image

Epilepsy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 280 Pages
  • Global
From
Erosive Hand Osteoarthritis - Pipeline Insight, 2025 - Product Thumbnail Image

Erosive Hand Osteoarthritis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Erythropoietic Protoporphyria - Pipeline Insight, 2025 - Product Thumbnail Image

Erythropoietic Protoporphyria - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Eye Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Eye Infections - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Eye Neoplasms - Pipeline Insight, 2025 - Product Thumbnail Image

Eye Neoplasms - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Fibrodysplasia Ossificans Progressive - Pipeline Insight, 2025 - Product Thumbnail Image

Fibrodysplasia Ossificans Progressive - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Fibromyalgia - Pipeline Insight, 2025 - Product Thumbnail Image

Fibromyalgia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Galactosemia- Pipeline Insight, 2025 - Product Thumbnail Image

Galactosemia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Gastroesophageal Reflux Disease (GERD) - Pipeline Insight, 2025 - Product Thumbnail Image

Gastroesophageal Reflux Disease (GERD) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Gaucher Disease Type 1 - Pipeline Insight, 2025 - Product Thumbnail Image

Gaucher Disease Type 1 - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Gaucher's Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Gaucher's Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Geographic Atrophy (GA)- Pipeline Insight, 2025 - Product Thumbnail Image

Geographic Atrophy (GA)- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Glaucoma - Pipeline Insight, 2025 - Product Thumbnail Image

Glaucoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 170 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more